Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Summary

The primary purpose of this study is to assess the safety and tolerability of TRx0237 when taken at the same time as acetylcholinesterase inhibitors (i.e., donepezil, galantamine, or rivastigmine) and / or memantine to treat patients with mild to moderate Alzheimer's Disease.

Timeline

Start

2012-09

Primary completion

2013-03

Completion

2013-03

Outcome

Outcome not reported

Stopped: “This study has been terminated for administrative reasons only.”

Drugs

Indications